The quality of cancer genomic and proteomic data relies upon the quality of the clinical
specimens examined. Here, we show that data derived from non-microdissected …

Introduction Discrimination between (high-grade) brain tumor recurrence and radiation
necrosis (RN) remains a diagnostic challenge because both entities have similar imaging …

Gliomas are one of the most devastating primary brain tumors which impose significant
management challenges to the clinicians. The aggressive behaviour of gliomas is mainly …

Introduction Glioblastoma with oligodendroglioma component (GBM-O) was recognized as a
histologic pattern of glioblastoma (GBM) by the World Health Organization (WHO) in 2007 …

Overview: Glioblastoma (GBM) is a highly malignant, rapidly progressive astrocytoma that is
distinguished pathologically from lower-grade tumors by necrosis and microvascular …

The movement to create guidelines for management of medical maladies has been gaining
strength for quality, academic, financial and political purposes over the past two decades …

Abstract Target Population These recommendations apply to adult patients with newly
diagnosed or suspected glioblastoma (GBM) Question For adult patients with newly …

Glioblastoma remains one of the most difficult cancers to treat and represents the most
common primary malignancy of the brain. Although conventional treatments have found …

Glioblastoma multiforme is one of the most common intracranial tumors encountered in
adults. This tumor of very poor prognosis is associated with a median survival rate of …

Purpose: Dynamic PET studies with a 68 Ga-Bombesin analog, the 68 Ga-BZH 3, were
performed in patients with highly suspected recurrent gliomas to investigate the effect of the …